Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of persistent allergic urticaria.~* Age over 12 years and at least one year with the disease~* Informed consent filled.~* Be resident of the metropolitan area of Medellin.~Exclusion Criteria:~* • Use of immunosuppressive drugs

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Cetirizine (Type: ACTIVE_COMPARATOR): Cetirizine
- Desloratadine (Type: ACTIVE_COMPARATOR): desloratadine
- Fexofenadine (Type: ACTIVE_COMPARATOR): Fexofenadine
- Ebastine (Type: ACTIVE_COMPARATOR): ebastine
- Bilastine (Type: ACTIVE_COMPARATOR): bilastine

Based on this trial design, predict the completion outcome and termination type (if applicable).